Fisher & Paykel Healthcare Corp. Ltd. engages in the design, manufacture, and marketing of products and systems for use in acute and chronic respiratory care, surgery, and treatment of obstructive sleep apnea. The firm provides medical device products and systems for use in both hospital and homecare settings. Its hospital product group includes products used in invasive ventilation, noninvasive ventilation, nasal high flow therapy, anesthesia, and laparoscopic and open surgery. Its homecare product group includes devices and systems used to treat obstructive sleep apnea (OSA) and provide respiratory support in the home, which include its continuous positive airway pressure (CPAP) therapy masks as well as flow generators, interfaces, and data management technologies. The Company’s products are sold in over 120 countries worldwide. The company operates across Canada, the United States of America, Mexico, Costa Rica, the United Kingdom, Switzerland, India, and others.
Follow-Up Questions
Who is the CEO of Fisher & Paykel Healthcare Corporation Ltd?
Mr. Lewis Gradon is the Chief Executive Officer of Fisher & Paykel Healthcare Corporation Ltd, joining the firm since 2001.
What is the price performance of FSPKF stock?
The current price of FSPKF is $20.95, it has decreased 0% in the last trading day.
What are the primary business themes or industries for Fisher & Paykel Healthcare Corporation Ltd?
Fisher & Paykel Healthcare Corporation Ltd belongs to Health Care industry and the sector is Health Care
What is Fisher & Paykel Healthcare Corporation Ltd market cap?
Fisher & Paykel Healthcare Corporation Ltd's current market cap is $12.2B
Is Fisher & Paykel Healthcare Corporation Ltd a buy, sell, or hold?
According to wall street analysts, 15 analysts have made analyst ratings for Fisher & Paykel Healthcare Corporation Ltd, including 2 strong buy, 4 buy, 7 hold, 2 sell, and 2 strong sell
